Mauro Avanzi currently serves as Chief Medical Officer at Dispatch Bio since September 2025, following a similar role at Shoreline Biosciences, Inc. from February 2023 to September 2025. Prior experience includes Vice President of Clinical Development at Neogene Therapeutics and various leadership positions at Kite Pharma, where Mauro advanced from Medical Director to Executive Medical Director from October 2017 to January 2021. Mauro's academic training includes a PhD from the New York Blood Center and a medical degree from Pontifícia Universidade Católica de Campinas, along with postdoctoral research at Memorial Sloan Kettering Cancer Center, focusing on CAR T cell research. Mauro's extensive background encompasses over a decade in oncology, clinical development, and research in prestigious institutions.
This person is not in any teams
This person is not in any offices